UOC
DARE icon

UBS O'Connor’s Dare Bioscience DARE Stock Holding History

UBS O'Connor’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-420
Closed -$213K – 653
2014
Q3 		$213K Sell
420
-494
-54% -$263K ﹤0.01% 406
2014
Q2 		$636K Buy
+914
New +$705K ﹤0.01% 357

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS O'Connor's DARE Position: Q4 2014 in Review

UBS O'Connor sold out of Dare Bioscience (DARE) in Q4 2014, closing a stake of 420 shares — an estimated $213K sold.

UBS O'Connor first reported a position in DARE in Q2 2014 and held it in 2 quarters. The position peaked at $636K in Q2 2014. 16 funds tracked by Wall St. Rank hold DARE as of Q4 2014.

  • UBS O'Connor reported no remaining Dare Bioscience position as of Q4 2014 after selling out during the quarter.
  • UBS O'Connor sold 420 Dare Bioscience shares in Q4 2014, an estimated $213K.
  • UBS O'Connor first reported a position in Dare Bioscience in Q2 2014 and held it in 2 quarters.
  • UBS O'Connor's Dare Bioscience position peaked at $636K in Q2 2014.
  • 16 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2014.

Based on UBS O'Connor's 13F filing for Q4 2014, filed 13 Feb 2015.